glp 1 receptor antagonist drugs GLP-1 Agonists: An Alternative for Rapid-Acting Insulin? List of approved and pending
Description
About one-third of patients achieved 25% or greater weight loss
Reduced pricing could simplify coverage decisions and streamline patient access
GLP-1 and glucagon co-agonists Glucagon is secreted from the pancreatic a-cells and the main physiological site of action is the liver to increase hepatic glucose production [60]
Nonetheless, for new GLP-1 drugs in development, it is imperative to evaluate potential drug interactions since this drug class can alter the efficacy of concomitant medications or increase the risk of adverse events as a result of higher exposure to a co-administrated drug
Whereas liraglutide has been shown to cut a persons food intake by 15%, semaglutide reduced it by up to 35%
